Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy
US-9364494-B2 · Jun 14, 2016 · US
Cayla was listed as an assignee on 1 patent publication in 2016.
| Metric | Value |
|---|---|
| Company | Cayla |
| Year | 2016 |
| Patents | 1 |
Representative publications for Cayla in 2016.
Most common classification codes for Cayla in 2016.
| CPC | Patents |
|---|---|
| A61K2300/00 | 1 |
| A61K31/7068 | 1 |
| A61K38/1796 | 1 |
| A61K38/45 | 1 |
| A61K47/48192 | 1 |
Navigate to parent entity pages.